Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria

The objective of this paper was to determine the effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia (BPH) patients in Sokoto, Nigeria. Standard methods and procedures were used. At 2nd and 3rd months of tamsulosin use, there was a significant increase (P<0.05) in p...

Full description

Bibliographic Details
Main Authors: M Dikko, S.O. Bello, A. Chika, I.A. Mungadi, Y. Sarkingobir, A.I. Umar
Format: Article
Language:English
Published: Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP) 2020-05-01
Series:Journal of Applied Sciences and Environmental Management
Subjects:
Online Access:https://www.ajol.info/index.php/jasem/article/view/196068
_version_ 1797228082449350656
author M Dikko
S.O. Bello
A. Chika
I.A. Mungadi
Y. Sarkingobir
A.I. Umar
author_facet M Dikko
S.O. Bello
A. Chika
I.A. Mungadi
Y. Sarkingobir
A.I. Umar
author_sort M Dikko
collection DOAJ
description The objective of this paper was to determine the effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia (BPH) patients in Sokoto, Nigeria. Standard methods and procedures were used. At 2nd and 3rd months of tamsulosin use, there was a significant increase (P<0.05) in plasma insulin values compared to baseline. Likewise, at 4th month of tamsulosin use, a significant increase (P<0.05) in plasma insulin values was revealed compared to baseline and 2nd month values. Other inter-mean values comparisons were not significantly different (P>0.05). Plasma insulin at 4th months of the study in BPH patients (45-54 years) treated with tamsulosin revealed a significant increase (P<0.05) compared to baseline values. Other inter-mean values comparisons were not significantly different (P>0.05). BPH patients (aged 55-64 years) at 3rd month showed a significant increase (P<0.05) in plasma insulin values compared to baseline values. Likewise, at 4th month of tamsulosin use, a significant increase  (P<0.05) in plasma insulin values was seen compared to baseline and 1st month values. Other inter-mean values comparisons were not significantly different (P>0.05). In BPH patients aged 65 and above, there was no significant difference (P>0.05) in plasma insulin values from 1st through 4th month compared to baseline and other inter mean values comparisons. Plasma insulin at 0th , 1st , 2nd , 3rd and 4th months of BPH patients of different age groups treated with tamsulosin revealed no significant differences (P>0.05). This study revealed that tamsulosin use in the patients lead to significant increase in plasma insulin level (hyperinsulinemia). Careful and routine monitoring of BPH patients should be done. Patients need enough exercise activities and some drugs can be administered to alleviate elevated glucose or insulin. Keywords: Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance
first_indexed 2024-04-24T14:51:02Z
format Article
id doaj.art-313233b92e6b4055bfee702b4c2881ea
institution Directory Open Access Journal
issn 2659-1502
2659-1499
language English
last_indexed 2024-04-24T14:51:02Z
publishDate 2020-05-01
publisher Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP)
record_format Article
series Journal of Applied Sciences and Environmental Management
spelling doaj.art-313233b92e6b4055bfee702b4c2881ea2024-04-02T19:49:31ZengJoint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP)Journal of Applied Sciences and Environmental Management2659-15022659-14992020-05-0124410.4314/jasem.v24i4.1Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, NigeriaM DikkoS.O. BelloA. ChikaI.A. MungadiY. SarkingobirA.I. Umar The objective of this paper was to determine the effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia (BPH) patients in Sokoto, Nigeria. Standard methods and procedures were used. At 2nd and 3rd months of tamsulosin use, there was a significant increase (P<0.05) in plasma insulin values compared to baseline. Likewise, at 4th month of tamsulosin use, a significant increase (P<0.05) in plasma insulin values was revealed compared to baseline and 2nd month values. Other inter-mean values comparisons were not significantly different (P>0.05). Plasma insulin at 4th months of the study in BPH patients (45-54 years) treated with tamsulosin revealed a significant increase (P<0.05) compared to baseline values. Other inter-mean values comparisons were not significantly different (P>0.05). BPH patients (aged 55-64 years) at 3rd month showed a significant increase (P<0.05) in plasma insulin values compared to baseline values. Likewise, at 4th month of tamsulosin use, a significant increase  (P<0.05) in plasma insulin values was seen compared to baseline and 1st month values. Other inter-mean values comparisons were not significantly different (P>0.05). In BPH patients aged 65 and above, there was no significant difference (P>0.05) in plasma insulin values from 1st through 4th month compared to baseline and other inter mean values comparisons. Plasma insulin at 0th , 1st , 2nd , 3rd and 4th months of BPH patients of different age groups treated with tamsulosin revealed no significant differences (P>0.05). This study revealed that tamsulosin use in the patients lead to significant increase in plasma insulin level (hyperinsulinemia). Careful and routine monitoring of BPH patients should be done. Patients need enough exercise activities and some drugs can be administered to alleviate elevated glucose or insulin. Keywords: Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance https://www.ajol.info/index.php/jasem/article/view/196068Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance
spellingShingle M Dikko
S.O. Bello
A. Chika
I.A. Mungadi
Y. Sarkingobir
A.I. Umar
Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
Journal of Applied Sciences and Environmental Management
Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance
title Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
title_full Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
title_fullStr Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
title_full_unstemmed Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
title_short Effect of Tamsulosin Use on Plasma Insulin Status in Benign Prostatic Hyperplasia Patients in Sokoto, Nigeria
title_sort effect of tamsulosin use on plasma insulin status in benign prostatic hyperplasia patients in sokoto nigeria
topic Tamsulosin, hyperinsulinemia, benign prostatic hyperplasia patients, insulin resistance
url https://www.ajol.info/index.php/jasem/article/view/196068
work_keys_str_mv AT mdikko effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria
AT sobello effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria
AT achika effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria
AT iamungadi effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria
AT ysarkingobir effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria
AT aiumar effectoftamsulosinuseonplasmainsulinstatusinbenignprostatichyperplasiapatientsinsokotonigeria